Normalization oflactate dehydrogenase (LDH) as a potential prognostic factor for relapsed/refractory aggressive B-cell lymphoma (R/R BCL) patients receiving car t following bridging radiotherapy: Results from a multi-institutional ILROG CAR T consortium Meeting Abstract
| Authors: | Chelius, M.; Yegya-Raman, N.; Baron, J.; Jain, M. D.; Yahalom, J.; Imber, B. S.; Dandapani, S. V.; Ladbury, C. J.; Fang, P.; Wu, S. Y.; Braunstein, S. E.; Chew, J.; Sim, A. J.; Terezakis, S. A.; Sakthivel, G.; Tseng, Y. D.; Plastaras, J. P.; Chong, E. A.; Figura, N. B.; Hubbeling, H. G. |
| Abstract Title: | Normalization oflactate dehydrogenase (LDH) as a potential prognostic factor for relapsed/refractory aggressive B-cell lymphoma (R/R BCL) patients receiving car t following bridging radiotherapy: Results from a multi-institutional ILROG CAR T consortium |
| Meeting Title: | 66th Annual Meeting of the American Society for Radiation Oncology (ASTRO 2024) |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 120 |
| Issue: | 2 Suppl. |
| Meeting Dates: | 2024 Sep 29-Oct 2 |
| Meeting Location: | Washington, DC |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-10-01 |
| Start Page: | S205 |
| End Page: | S206 |
| Language: | English |
| ACCESSION: | WOS:001325892303218 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.ijrobp.2024.07.2273 |
| Notes: | Meeting Abstract: 1119 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work